HIF-1α Promotes Hepatocellular Carcinoma Metastasis by Regulating Angiogenesis and Epithelial-Mesenchymal Transition

Background: Invasion and metastasis of hepatocellular carcinoma (HCC) still remain to be hard in medical society. However, little knowledge is known regarding the hypoxia impact in HCC with angiogenesis and epithelial-mesenchymal transition (EMT). The aims of this study were to explore the regulating roles of hypoxia-inducible factor-1α (HIF-1α) in angiogenesis and EMT of HCC. Method: The levels of HIF-1α, angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF) expression in a cohort of chronic liver diseases were detected by enzyme- linked immunosorbent assays, and their dynamic up-regulations were confirmed in model of rat hepatocyte malignant transformation. After HIF-1α gene transfected with specific miRNA, biological behaviors of HCC cells were analyzed by transwell or invasion assay; angiogenesis and EMT were analyzed at protein level by Western blot or at mRNA by quantitative real-time PCR. Results: The levels of circulating HIF-1α, VEGF, and Ang-2 in the HCC group (145.6 ± 32.6 μg/L, 458.9 ± 125.3 μg/L, and 42.9 ± 5.1μg/L) were significantly higher (P < 0.001) than those in the LC (79.5 ± 8.4 μg/L, 206.8 ± 56.8 μg/L, and 26.2 ± 6.1 μg/L) or the CH (60.1 ± 18.8 μg/L, 178.1 ± 85.4 μg/L, and 21.8 ± 6.9 μg/L) group, respectively. Dynamic up-regulations of HIF-1α and angiogenic factors have been confirmed by rat model with hepatocyte malignant transformation. There were closely positive correlations (P < 0.001) between them of HIF-1α and VEGF or Ang-2. After HCC cells transfected with specific HIF-1α-miRNA, the levels of HIF-1α, VEGF and Ang-2 expression were significantly down-regulated, with inhibiting infiltration or migration, blockading EMT with increasing E-cadherin and decreasing of snail, twist and vimentin. Conclusions: HIF-1α over-expression could promote the metastasis or invasion of HCC via regulating neovascularization and EMT formation.

[1]  Gao-lin Liu,et al.  Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling , 2020, BMC Cancer.

[2]  K. Mortezaee Hypoxia induces core-to-edge transition of progressive tumoral cells: A critical review on differential yet corroborative roles for HIF-1α and HIF-2α. , 2019, Life sciences.

[3]  I. Berindan‐Neagoe,et al.  Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes , 2019, International journal of molecular sciences.

[4]  A. Vogel,et al.  Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. , 2019, Cancer treatment reviews.

[5]  Qiang Wang,et al.  6-C-(E-phenylethenyl)naringenin attenuates the stemness of hepatocellular carcinoma cells by suppressing Wnt/β-catenin signaling. , 2019, Journal of agricultural and food chemistry.

[6]  Quanzhou Peng,et al.  HIF-1-miR-219-SMC4 Regulatory Pathway Promoting Proliferation and Migration of HCC under Hypoxic Condition , 2019, BioMed research international.

[7]  Z. Dong,et al.  Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma , 2019, Journal of Cancer.

[8]  Hui Guo,et al.  Epithelial–mesenchymal transition induced cancer‐stem‐cell‐like characteristics in hepatocellular carcinoma , 2019, Journal of cellular physiology.

[9]  Zuqing Su,et al.  Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition. , 2019, International journal of biological macromolecules.

[10]  Ming Yan,et al.  Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma. , 2019, Biochimica et biophysica acta. Molecular cell research.

[11]  Z. Dong,et al.  Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[12]  松浦 雄祐 Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells , 2019 .

[13]  K. Shailubhai,et al.  Hepatocellular Carcinoma: Etiology and Current and Future Drugs. , 2019, Journal of clinical and experimental hepatology.

[14]  Liang Han,et al.  Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF , 2019, Oxidative medicine and cellular longevity.

[15]  Dan Wang,et al.  Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis. , 2018, Pathology, research and practice.

[16]  Y. Takeda,et al.  Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells , 2018, Digestive Diseases and Sciences.

[17]  Jia-chu Li,et al.  Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma , 2018, Scientific Reports.

[18]  M. Mayer,et al.  Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma , 2018, Oncogene.

[19]  R. Weinberg,et al.  New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature reviews. Molecular cell biology.

[20]  J. González‐Gallego,et al.  Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors , 2018, Experimental & Molecular Medicine.

[21]  R. Finn,et al.  The Role of Angiogenesis in Hepatocellular Carcinoma , 2018, Clinical Cancer Research.

[22]  Hong-wei Lei,et al.  Rapamycin Combi with TAE on the Growth, Metastasis, and Prognosis of Hepatocellular Carcinoma in Rat Models. , 2018, Annals of hepatology.

[23]  M. Petrillo,et al.  Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments. , 2018, Future oncology.

[24]  Linxi Chen,et al.  deSUMOylation signaling: a novel mechanism of liver CSC properties and hepatocarcinogenesis in hypoxia , 2017, Acta biochimica et biophysica Sinica.

[25]  Yi-xin Zhang,et al.  Cancer survival in Qidong between 1972 and 2011: A population-based analysis. , 2017, Molecular and clinical oncology.

[26]  Baocun Sun,et al.  HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment , 2017, Journal of experimental & clinical cancer research : CR.

[27]  Tao Lou,et al.  Hypoxia inducible factors in hepatocellular carcinoma , 2017, Oncotarget.

[28]  B. Luo,et al.  Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion , 2017, Cancer science.

[29]  I. Ng,et al.  SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop , 2017, Gut.

[30]  P. Hu,et al.  LHBs can elevate the expression of MDR1 through HIF-1α in patients with CHB infection: a comparative proteomic study , 2016, Oncotarget.

[31]  Yong Xie,et al.  AEG-1 is associated with hypoxia-induced hepatocellular carcinoma chemoresistance via regulating PI3K/AKT/HIF-1alpha/MDR-1 pathway , 2016, EXCLI journal.

[32]  Xiao-Ming Zhang,et al.  The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma , 2016, Journal of clinical medicine research.

[33]  Jennifer Wu,et al.  Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target. , 2015, World journal of gastroenterology.

[34]  Shan Li,et al.  Association between hypoxia-inducible factor-1α gene polymorphisms and risk of chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: a retrospective case-control study. , 2015, Gene.

[35]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[36]  Q. Ni,et al.  Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma , 2011, Hepatitis monthly.

[37]  K. Nan,et al.  Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. , 2011, International journal of oncology.

[38]  Wei Wu,et al.  Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma. , 2009, Hepatobiliary & pancreatic diseases international : HBPD INT.

[39]  Jian-Li Hu,et al.  Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells. , 2017, Oncology reports.

[40]  D. Yao,et al.  Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. , 2000, Cancer.